Amedeo's Top 20

Amedeo Smart

Independent Medical Education

13 June 2022

Multidisciplinary Journal Club

  1. Danese S, Vermeire S, Zhou W, Pangan AL, et al.
    Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
    Lancet 2022.

  1. Sneller MC, Blazkova J, Justement JS, Shi V, et al.
    Combination anti-HIV antibodies provide sustained virological suppression.
    Nature 2022.

  2. Ramakrishna N, Anders CK, Lin NU, Morikawa A, et al.
    Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update.
    J Clin Oncol 2022.

  3. Evers S, Frese A, Summ O, Husstedt IW, et al.
    Levetiracetam in the prophylactic treatment of episodic migraine: A prospective open label study.
    Cephalalgia 2022.

  4. Bernabei JM, Sinha N, Arnold TC, Conrad E, et al.
    Normative intracranial EEG maps epileptogenic tissues in focal epilepsy.
    Brain 2022.

  1. Gardner CD, Landry MJ, Perelman D, Petlura C, et al.
    Effect of a Ketogenic Diet versus Mediterranean Diet on HbA1c in Individuals with Prediabetes and Type 2 Diabetes Mellitus: the Interventional Keto-Med Randomized Crossover Trial.
    Am J Clin Nutr 2022.

  2. Giordano SH, Franzoi MAB, Temin S, Anders CK, et al.
    Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update.
    J Clin Oncol 2022.

  3. Pelzer PT, Smit Y, Tiemersma EW, Huong NT, et al.
    Does BCG vaccination protect against infection with M. tuberculosis?
    Int J Tuberc Lung Dis 2022;26:529-536.

  4. Raphael MJ, Karanicolas PJ.
    Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?
    J Clin Oncol 2022.

  5. Josephs KA, Weigand SD, Whitwell J.
    Characterizing Amyloid Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Neurology 2022.

  1. Takata H, Trautmann L.
    Transforming dysfunctional CD8+ T cells into natural controller-like CD8+ T cells: can TCF-1 be the magic wand?
    J Clin Invest 2022;132.

  2. Wise RA, Holbrook JT, Brown RH, Criner GJ, et al.
    Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative LEEP Trial.
    Am J Respir Crit Care Med 2022.

  3. LeBlanc ES, Hovey KM, Cauley JA, Stefanick M, et al.
    Cumulative Endogenous Estrogen Exposure is Associated with Postmenopausal Fracture Risk: The Women's Health Initiative Study.
    J Bone Miner Res 2022.

  4. Bettini S, Milan G, Favaretto F, Fabris R, et al.
    Metabolic slowing vanished 5 years after sleeve gastrectomy in patients with obesity and prediabetes/diabetes.
    J Clin Endocrinol Metab 2022.

  5. Vandenput L, Johansson H, McCloskey EV, Liu E, et al.
    Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Osteoporos Int 2022.

  1. Holden RM, Booth SL, Zimmerman D, Moist L, et al.
    Inhibit progression of coronary artery calcification with vitamin k in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-centre, pilot trial.
    Nephrol Dial Transplant 2022.

  2. Jin EH, Han K, Lee DH, Shin CM, et al.
    Association between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed before 50 years According to Tumor Location.
    Gastroenterology 2022.

  3. Wilcox ME, Rowan KM, Harrison DA, Doidge JC, et al.
    Does Unprecedented ICU Capacity Strain, As Experienced During the COVID-19 Pandemic, Impact Patient Outcome?
    Crit Care Med 2022;50:e548-e556.

  4. Hou X, Guan H, Sun S, Shi Y, et al.
    Outcomes of Early-pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-up Study.
    Thyroid 2022.

  5. Mutter T, Logan GS, Neily S, Richardson S, et al.
    Postoperative neurologic symptoms in the operative arm after shoulder surgery with interscalene blockade: a systematic review.
    Can J Anaesth 2022;69:736-749.


more..

Privacy Policy